INTRODUCTION
Circular dichroism (CD) is an excellent technique to study the folding and interactions of proteins. Machines capable of obtaining measurements below 250 nm, where the protein backbone amides absorb light, first became available commercially B40 years ago. At that time, very little was known about the structure of proteins, and the principal application of CD was to determine the secondary structure of newly isolated proteins. However, CD is more valuable as a rapid method to study protein folding and interactions.
When the amide polypeptide bonds are aligned in regular arrays, such as a-helices or b-pleated sheets, they have characteristic spectra. For example, proteins with high contents of a-helices have characteristic bands at 222 and 208 nm. Two examples of such proteins are shown in Figure 1 . The addition of ligands, denaturants or stabilizing agents, such as osmolytes, to proteins often changes their CD spectra. Thus, CD can be used to study the effects of denaturants or osmolytes on protein folding, or to determine ligand binding constants. Figure 1a illustrates how the addition of guanidine HCl (Gn-HCl) to a helical protein causes a loss of the characteristic helical CD bands 1 , which can be used to determine the free energy of folding of the protein. Figure 1b illustrates how the addition of calcium to the calcium binding subunit of troponin causes an increase in its ellipticity due to an increase in helical content 2 . The change in ellipticity can be used to determine the calcium binding constants. In addition, when ligands with chromophores bind to proteins they may develop strong extrinsic CD bands that can be used to determine binding constants. Figure 1c shows the CD bands that are induced when folate binds to dihydrofolate reductase from Escherichia coli 3 . The induced extrinsic ellipticity can be used to determine the binding constant of the ligand.
Sources of spectrometers and cuvettes, setting up CD machines to collect data and the procedures for obtaining high-quality, reproducible data have been covered 4 . This protocol will cover methods for obtaining data as a function of titrants, including denaturants, osmolytes and ligands, and for analyzing data to determine the free energy of protein folding and the binding constants of protein-ligand (or protein-protein) interactions. This protocol will cover only the basics of each application. For more detailed information, there are several reviews and illustrative articles that cover the use of CD spectroscopy to determine the free energy of folding using denaturants or osmolytes [5] [6] [7] [8] [9] [10] [11] [12] [13] and to study interactions of proteins with ligands, other proteins and polynucleotides [14] [15] [16] [17] [18] [19] .
Description of methods
The two methods to be described address the determination of the free energy of protein folding from changes in CD as a function of denaturants or osmolytes (A), as well as the determination of binding or dissociation constants from changes in CD as a function of ligand concentration (B). Before beginning any titration experiments make sure that the protein to be studied gives a high-quality CD spectrum 4 and that the spectrum changes upon addition of a denaturant, osmolytes or ligand.
(A) Determination of the free energy of folding by following changes in the ellipticity of a protein as a function of denaturants or osmolytes The free energy of folding of a protein can be determined from CD measurements as a function of denaturants or osmolytes if the change in CD is due to a two-state transition between folded and unfolded states. To a first approximation the free energy is linearly dependent on the concentration of denaturants, such as urea or guanidine, which cause a loss of ellipticity, or osmolytes, such as trimethylamine N-oxide (TMAO) or sucrose, which increase the stability of proteins and cause an increase in ellipticity 12, 20 . Note: if this method is to be used to determine true thermodynamic parameters, the unfolding of a protein must be reversible; i.e., the folding at each concentration of denaturant must be identical whether the denaturant is added to the folded protein or the denaturant is diluted out of the solution by added denaturant-free protein in buffer. The folding constant, K F , of a monomeric protein or polypeptide can be evaluated by the equation: 
where P t is the total protein concentration. For a multimeric protein with identical chains the equation is:
where P t is the molecular concentration of the multimeric protein when all the protein is folded, i.e., the total concentration of chains/n. For a multimeric protein where all the chains are unique the equation is:
The free energy of folding of a protein, DG F , can be evaluated from the equation:
where R is the gas constant ¼ 1.98 cal/mol and T is the absolute temperature.
In this protocol, the free energy is calculated in terms of moles of folded protein, e.g., 1 mol of a folded homodimeric protein, A, unfolds to give 2 mol of unfolded chains, B. For many proteins, the free energy of folding is a linear function of the amount of titrant added 8, 12, 20 .
where DG i is the free energy of the protein in the presence of the i th concentration of denaturant, DG 0 is the free energy of the folded protein in the absence of denaturant, m is the slope and [D] i is the concentration of denaturant.
To determine the free energy of folding using linear regression, (1) determine K Fi of folding at each concentration of titrant, [D] i using equations 2 and 3 for a monomer, or 2 and 4 or 5 as appropriate for multimers; (2) calculate the free energy at each condition using equation 6; (3) plot DG Fi (y) as a function of denaturant (x), and fit the data to a straight line, y ¼ mx + b, where m is the slope and b is the y intercept. The free energy of folding, DG 0, is equal to the y intercept. The unfolding curves can also be evaluated directly from the ellipticity, [y] i , as a function of denaturant, [D] i , using nonlinear regression routines such as the Levenberg-Marquardt algorithm 21 found in many graphics programs as shown here.
For a monomer:
where M is the slope.
where R is the gas constant, which equals 1.98 cal/mol, and T is the absolute temperature.
The theoretical ellipticity, Y is fit to the observed data, 
where P t is the total protein concentration when it is fully folded as a dimer. For a homodimer equation 12 is replaced by:
Occasionally, there will be small changes in the CD spectrum of a protein as a linear function of perturbant preceding and/or following the major unfolding transition. Large linear changes in the spectral parameters of the folded and unfolded state of proteins are often seen when folding is monitored by changes in the fluorescence of the aromatic residues or difference spectroscopy in the aromatic region of the spectrum. 
Here m 1 and m 2 are the slopes of the linear pretransition and posttransition changes, respectively. They are input as additional parameters in the curve fitting routines. The linear correction terms should only be applied when it is clear that there are true linear changes in ellipticity of the fully unfolded and folded forms of the protein as a function of the titrant. Fits of raw data are almost always improved when the number of parameters to be fitted is increased, but the parameters often become highly dependent on one another and the results may be misleading. In addition, the pre-and post-transition 'linear' changes in CD may indicate that the unfolding transitions are not two-state between a single folded and unfolded form. There may be small local unfolding transitions that contribute to the total free energy of unfolding. Denaturation studies can be used to determine the association constants of protein-protein complexes if the folding is reversible and the proteins only bind to each other when folded. In the simplest case both proteins (e.g., X and Y) are monomers. 
To determine the binding constants of a dimer, first determine the free energies of folding of the free proteins and the protein complex from the linear plots of the free energies of folding DG i as a function of [D] i , and extrapolate to zero denaturant concentration to obtain values of DG 0 . Calculate the folding constants in the absence of denaturant using the relationship k F ¼ e -Go/RT . R is the gas constant and T is the absolute temperature. Divide the k F of folding of the dimer by the product of the k F values of folding of the two monomers to get the binding constant, K A , for dimer formation.
In some cases the free energy of folding is not strictly a linear function of the concentration of denaturant. Such nonlinearity is most often seen when proteins are denatured using Gn-HCl, and may arise from charge-charge interactions between the protein and denaturant 22 . A complete discussion of these cases is beyond the scope of this protocol, but there are several articles in the literature that discuss the treatment of nonlinear data in detail [22] [23] [24] .
The free energy of folding of a protein that is intrinsically disordered can be determined by adding osmolytes such as TMAO, sucrose, sorbitol or glycerol 13, 25 , which induce folding. In this case, increasing concentrations of osmolytes are added to the protein solution until there is no further increase in ellipticity. The final ellipticity value corresponds to [y] F. Wu and Bolen 13 have pointed out that if the native protein is not completely unfolded in the absence of osmolytes, its ellipticity is not equal to [y] U and the linear extrapolation method will not give the correct DG of folding. They suggest titrating the protein solution in the absence of osmolytes with urea to determine the parameter corresponding to the completely unfolded protein (in this case [y] u ), which can then be used to determine the fraction folded using equation 2.
Routines for fitting the change in ellipticity as a function of denaturant or osmolytes to determine the free energy of folding are in Supplementary Equations online in SigmaPlot format. (B) The determination of binding or dissociation constants from changes in ellipticity as a function of ligands, nucleic acids or other proteins The general theory of binding equilibria has been discussed in several classical articles and books [26] [27] [28] [29] [30] , and a complete analysis is beyond the scope of this protocol. There are also several detailed reviews covering the use of CD and spectroscopy in general to measure protein-protein and protein-ligand interactions 14, 15, 18, 19, [31] [32] [33] [34] [35] , so only illustrative examples will be given here.
If one titrates a protein, P, with another protein or a ligand, A, the concentration of product [PA] formed is in equilibrium with free [P] and [A] . The dissociation constant of the complex is defined as K d , and the association constant K A is equal to 1/K d . 30 .
In the Scatchard plot the change in ellipticity as a function of free ligand concentration, [A] , is transformed into a linear plot, shown in equation 20 .
To determine the binding constant and the proportionality constant, one plots
The slope is the association constant and the x intercept is e.
In the Hill plot, the change in ellipticity as a function of ligand concentration is described by equation 21, which is not linear.
The 
where n is 1/number of binding sites. Comparisons with other methods CD, like all other spectroscopic methods, is an indirect way of determining the free energy of folding of proteins and protein binding interactions. The advantage of CD is that one gets information about the structural changes of the protein in response to perturbants and ligands, and CD is a relatively rapid method of studying folding and binding. However, as with all other spectroscopic techniques, the values that are obtained are model dependent. For example, when a protein is titrated to determine binding or dissociation constants, the assumption is made that the maximal change in ellipticity corresponds to maximal binding. For accurate determinations of either folding or binding constants, the stoichiometry of the reaction (i.e., number of binding sites, and/or oligomeric state of the protein) must be confirmed by independent methods such as equilibrium dialysis or ultracentrifugation. In addition, CD is most useful for determining dissociation constants ranging from 0.01 to 1 mM, because CD measurements are usually obtained on samples ranging from 0.005 mg ml -1 in a 1-cm cell to 1 mg ml -1 in a 0.1-cm cell. If a protein has a molecular weight of 20,000 the lowest practical concentration would be 0.1 mM, which would give a lower limit for the determination of a dissociation constant of 0.01 mM. The binding of more tightly bound ligands would be almost linear with concentration until saturation was reached (i.e., almost stoichiometric). Thus, CD is often not as sensitive as other spectroscopic methods, such as fluorescence.
Applications
Chemical perturbation of protein CD has many applications. Perusal of the PubMed database (http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?DB¼pubmed) shows that there have been 41,000 articles published following the interactions of proteins with Gn-HCl using CD. A primary application is to examine the effects of naturally occurring mutations on protein stability. In addition, as detailed earlier, the technique can be used to determine the binding constants of protein-protein, protein-DNA and protein-ligand interactions. Similarly, there are many applications of following titrations of proteins with ligands. The principal applications are examining the interaction of proteins with drugs 19, 39 and examining the effects of mutations on ligand binding. . Small stirring bars that will fit inside a rectangular 1-cm Â 1-cm cuvette.
REAGENT SETUP
For these experiments, four solutions are required: (1) a protein solution, (2) a solution containing both protein and the denaturant, osmolyte or ligand of interest, (3), buffer without protein and (4) ligand without protein. The protein concentration range and pathlengths of the CD cells depend on the type of experiment. Cases 1 and 2 cover the reagent setups for following the interaction of proteins with denaturants or osmolytes in the far-UV and near-UV to visible regions of the spectrum, respectively. Cases 3 and 4 cover the reagent setups for following the titration of proteins with ligands in far-UV or in the near-UV and visible regions, respectively. Case 1. Measuring the interactions of the protein amide backbone with denaturants, osmolytes or other perturbants to follow changes in secondary structure Most proteins have strong CD bands arising from the peptide backbone between 220 and 190 nm. Denaturants such as urea and Gn-HCl, however, absorb strongly below 220 nm. For the best signal-to-noise ratio, when the absorption of the perturbant plus protein is relatively high, i.e., 41 in a 1-cm cell at 218-222 nm, the protein concentration should be 0.1-0.2 mg ml -1 protein and CD spectra should be obtained in cuvettes with pathlengths of 0.05-2 cm to maintain the total absorbance at o1. Case 2. Measuring the interactions of the aromatic amino acids or prosthetic groups with denaturants or osmolytes to follow changes in tertiary structure The CD bands arising from aromatic amino acids (between 350 and 250 nm) and prosthetic groups such as flavins and hemes (in the visible region of the spectrum) are 100-fold weaker than the ellipticity of the peptide backbone.
However, the absorbance of most denaturants and osmoytes are negligible above 250 nm. Protein concentrations of B1-2 mg ml -1 are usually required, and measurements should be made in 1-cm cuvettes. Case 3. Determining titration curves of proteins with ligands by following changes in the ellipticity of the amide backbone when the absorption of the ligand plus protein at 218-222 nm is o1 in a 1-cm cell Many ligands including substrates, inhibitors, oligomers of DNA or RNA, metals or other proteins have very low absorption bands between 218 and 222 nm, or have absorptions comparable to that of the protein to be titrated. In these cases it is preferable to prepare solutions of 0.01-0.02 mg ml -1 protein and examine the spectral changes in cells with 1-cm pathlengths. The use of lower protein concentrations and larger volumes makes it easier to determine binding constants for ligands with high affinities. It is also easier to aliquot precise volumes of the solution containing the titrant and mix the solutions thoroughly when larger volumes are used. Case 4. Determining titration curves of proteins with ligands by following changes in the aromatic region or induction of extrinsic CD bands upon ligand binding Because CD bands of the aromatic groups and most bound ligands are weak, studies should be performed using 1-to 2-mg ml -1 solutions in cells with 1-cm pathlengths. Solution 1A (Case 1) 0.2-0.4 ml of a 0.1-to 0.2-mg ml -1 solution of protein dissolved in a buffer with low absorbance between 260 and 200 nm. The absorption properties of buffers has been described 4 . Solution 1B (Case 2) 2-4 ml of 1-to 2-mg ml -1 protein dissolved in a buffer that does not absorb in the near UV or visible region (most buffers). Solution 1C (Case 3) 2-4 ml of 0.01-to 0.02-mg ml -1 protein dissolved in a buffer with low absorbance 4 [40] [41] [42] . Solution 2B (Case 2) 2-5 ml of a stock solution containing the same concentration of protein as solution 1B with denaturants, osmolytes or ligands as described for solution 2A. Solution 2C (Case 3) 2-5 ml of a stock solution containing the same concentration of protein as solution 1C plus a 5-to 10-fold molar excess of ligand (e.g., substrate or inhibitor), 5-to 10-fold excess of a second protein or polynucleotide if the ligand has a high affinity, or high concentrations, BmM, of ligands, if the binding is very weak. Solution 2D (Case 4) 2-5 ml of a stock solution containing the same concentration of protein as solution 1D plus a 5-to 10-fold molar excess of ligand (e.g., substrate or inhibitor). Solution 3 Buffer used to prepare solutions 1A, 1B, 1C or 1D.
Solution 4 Ligand at same concentration used to prepare solution 2C or 2D. EQUIPMENT SETUP Procedures for setting up the machine to collect data, i.e., flushing with nitrogen, turning on the lamp, setting the temperature, the wavelength range, the bandwidth, the step size, and so on have been described 4 . Make sure that the instrument is flushed with nitrogen before firing the lamp. Turn on the lamp before turning on the instrument and computer to avoid damaging electronics when the lamp is fired. Make sure that circulating water baths or water supply if they are needed for cooling the lamp or acting as a heat trap for the temperature controllers are turned on before the CD machine is started. Some CD machines have automatic titrating accessories that work with cells with 1-cm pathlengths and will remove solutions from the sample compartment when the cell begins becoming full, so that one does not have to change samples during a titration, when the volume of titrant exceeds the volume capacity of the cuvette. Before using such attachments, however, test them with water to make sure that they do not leak and that they deliver accurate volumes. Software A commercial graphics program that allows user-defined nonlinear least squares curve fitting. Most of the commonly available commercial programs use the Levenberg-Marquardt algorithm 21 for fitting curves to nonlinear equations. Graphic packages include: GraphPad, http://www.graphpad. com/; Psi-Plot, http://www.polysoftware.com/aboutpsi.htm; Origin, http:// www.originlab.com; and SigmaPlot, http://www.systat.com. 
PROCEDURE Preliminary experiments 1|

4|
Obtain the spectrum of solution 2A, 2B, 2C or 2D using the same conditions as the spectrum of the protein alone to determine whether the addition of the denaturant or ligand has an effect on the protein structure, or induces the appearance of an extrinsic CD band before starting a titration.
5|
If the ligand has a spectrum, subtract the sum of the CD spectra of the ligand and the free protein from the spectrum of the protein-ligand mixture, to make sure that there is a measurable change upon interaction. (ii) After the addition, seal the cell tightly with a Teflon stopper and carefully mix the solutions. Then take the spectrum of the mixture. It is best to take two or three spectra to make sure that the protein is equilibrated with the perturbant and that the spectrum is not changing as a function of time. Save the spectra. Alternatively, set the machine to record data at a single wavelength as a function of time. Collect data for 1-2 min at 1-s intervals at 260 or 250 nm and save the data, and at 222 nm (or other wavelength with high ellipticity) and save the data. Calculate the difference of the average values of the ellipticity at the two wavelengths. (Note that some CD machines have functions to allow one to automatically compute the average value and slope of the data collected as a function of time.) (iii) Continue adding aliquots and taking CD measurements until the cell is filled. (iv) Make a fresh sample of a mixture containing 0.2 ml of a mixture of solutions 1A and 2A and then add aliquots of 2A to the fresh solution. (B) Case 2. Measuring the interactions of the aromatic amino acids or prosthetic groups with denaturants or osmolytes to follow changes in tertiary structure (i) Using a strategy similar to that shown in option A, add 0.1-to 0.5-ml aliquots of solution 2B to 2 ml of solution 1B, and mix with a magnetic stirring bar. (ii) Take a spectrum or record the ellipticity at two different wavelengths after each addition of solution 2B as described in option A. (iii) When the total volume equals 3 ml, the mixture of solutions 1B and 2B can be carefully removed from the cuvette and saved, the cell cleaned and dried, and 2 ml of saved solution added back to the cell and the titration continued. Alternatively, a fresh mixture of solutions 1B and 2B totaling 2 ml can be prepared and the titration continued. (C) Case 3. Determining titration curves of proteins with ligands by following changes in the ellipticity of the amide backbone when the absorption of the ligand plus protein at 218-222 nm is o1 in a 1-cm cell (i) Add small aliquots, 0.01-0.05 ml, of solution 2C to solution 1C as described in option B, and collect the data after each addition as described in option A. (Tmod1 160-359 ), is titrated with guanidine-HCl (Gn-HCl) 1 . Solution 1A contains Tmod1 160-359 , 0.24 mg ml -1 (10 mM), in 100 mM NaCl, 10 mM sodium phosphate, pH 6.5. Solution 2A contains 0.24 mg ml -1 Tmod1 160-359 in 100 mM NaCl, 10 mM sodium phosphate and 4.8 M Gn-HCl, pH 6.5. The titration is performed in a cuvette with a 0.1-cm pathlength and a sample volume capacity of 0.35 ml.
14| If full spectra were collected at each ligand or perturbant concentration, examine the spectra sets and pick the wavelength at which the ellipticity change is the greatest, or the signal-to-noise ratio the highest, and create a file of the ellipticity at the desired wavelength (y) as a function of ligand or titrant (x).
15| If changes in the backbone folding due to addition of denaturants or osmolytes have been determined, analyze the data to determine the free energy of folding. In the case of monomers or dimers the data may be fitted directly by nonlinear least squares analysis using equations [8] [9] [10] [11] [12] [13] [14] [15] [16] . For proteins with more than two subunits it is easier to calculate the free energies of folding at each concentration of titrant using equations 2-7 and determine the free energy of folding by plotting the free energy as a function of titrant and extrapolating to zero additions. Step
The baseline is not flat Run a spectrum without a cell to make sure the baseline with nitrogen is flat. Clean the cell as described 4 2
The protein sample has very low ellipticity between 250 and 200 nm
Check that the protein concentration is correct as described 4 
5
There is no change in ellipticity upon mixing the ligand or titrant with the protein Not all ligands will become optically active or change the conformation of a protein upon binding. In addition, some proteins are resistant to denaturants such as urea. If this is the case, check if the addition of ligand or titrant changes the stability to thermal denaturation and use this method to determine the binding constants or free energy of folding 47 
9
The ellipticity changes as a function of time Figure 2 shows the unfolding of three monomeric fragments of an actin capping protein, tropomodulin 1, as a function of increasing Gn-HCl concentrations. Figure 2a shows how the spectrum of one of the fragments, Tmod1 160-359, changes between 260 and 215 nm as a function of Gn-HCl. (The scheme used to collect the data for this fragment is given in Table 1 .) The high absorbance of guanidine precludes accurate CD measurements below 215 nm. Figure 2b shows the change in ellipticity at 222 nm of all three fragments. The data were fitted by equations 8-13 using nonlinear least squares analysis 21 . Figure 2c shows the plots of DG versus Gn-HCl. DG was calculated using equations 2, 3 and 7. The free energies of folding of the three fragments, calculated by direct fitting of the unfolding curves and by transforming the data to a plot of the free energy of folding as a function of denaturant concentration, are almost identical and are summarized in Table 3 . Figure 3 illustrates the titration of a recombinant subunit of troponin, troponin C, with Ca 2+ . Measurements were made in a solution containing a mixture of nitrilotriacetic acid and EGTA, which act as a calcium buffering system. Increasing amounts of a 9.01 mM CaCl 2 stock were added to the buffered protein, and the pH was maintained by adding an equimolar amount of KOH after each Ca 2+ addition. The free-Ca 2+ concentrations corresponding to the total calcium added were calculated from the binding constants of Ca 2+ for nitrilotriacetic acid and EGTA 40 using the computational method of Perrin and Sayce 41, 43, 44 . The protein has two classes of binding sites, which each bind two molar equivalents of calcium. The data were fitted by the sum of two independent Hill equations (equation 21) to determine the binding affinities and the Hill coefficients (a measure of cooperativity) for each site 37 . In three triplicate experiments, 65% ± 8.5% of the ellipticity change was due to binding to the first class of sites, and 35% ± 8% binding to the second class of sites. The dissociation constants were 0.086 ± 0.007 and 4.1 ± 0.9 mM, respectively, and the Hill coefficients were 2 ± 0.7 and 1.0 ± 0.05, respectively 45 . Figure 4 illustrates the titration of a protein with a ligand where the binding is tight and only the total ligand concentration is known. In this figure, dihydrofolate reductase is titrated with one of its substrates, folate. When folate binds to the enzyme, the ligand binds asymmetrically and large extrinsic CD bands are induced, one with a positive band near 292.5 nm and one with a negative band near 270 nm (ref.
3) (Fig. 1c) . Folate alone has almost no ellipticity at these concentrations. The change in ellipticity between 292.5 and 270 nm as a function of ligand was fitted assuming there was tight binding 38 When folate binds to dihydrofolate reductase from E. coli, its absorption bands become optically active 3 . , The change of the difference in ellipticity between 292.5 and 270.0 nm of dihydrofolate reductase from E. coli as a function of increasing folate concentration (line), The data fitted by equation 23 (ref. 38) to determine the number of binding sites per mole (0.95), the maximal ellipticity change (28 mdeg) and the dissociation constant, 3.1 mM. The enzyme was 9.2 mM in 0.1 M NaCl, pH 7.2, at 27 1C.
algorithm 21 to determine the maximal ellipticity change (28 mdeg), the number of binding sites (0.95) and the dissociation constant of the enzyme-substrate complex (3.1 mM). These values agree with those estimated from linear transformation of the data using the method of Kurganov et al. 3, 46 .
Supplementary materials: Two files with equations for determining the free energy of folding from chemical perturbation studies and for estimating binding constants for use with curve fitting programs are in the file Supplementary Equations. The equations are in SigmaPlot (Systat Software, Inc.) format but can easily be modified for use with other graphics programs. . 1) , respectively, were studied as a function of Gn-HC1 as shown in Figure 2 . b The data in Figure 2b were fitted by equations 8-13 using the Levenberg-Marquardt 21 algorithm implemented in SigmaPlot (Systat Software). c The data in Figure 2c were fitted to the line y ¼ mx + b, where y is the free energy at each concentration of Gn-HCl, x is the concentration of Gn-HCl, m is the slope and b, the y intercept, equals the free energy in the absence of denaturant. The data were fitted using the LevenbergMarquardt algorithm 21 . In both cases the estimated errors in the free energies are the standard errors of the parameters estimated from the curve fitting (one determination for each curve).
